Zentek Ltd. (ZTEK)

CA — Healthcare Sector
Peers: PDEX  ASRT  HYFT  FBIO  IMUX  UNCY  INCR  RPTX  EDAP 

Automate Your Wheel Strategy on ZTEK

With Tiblio's Option Bot, you can configure your own wheel strategy including ZTEK - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol ZTEK
  • Rev/Share 0.0088
  • Book/Share 0.1338
  • PB 8.4806
  • Debt/Equity 0.1341
  • CurrentRatio 1.6221
  • ROIC -0.41

 

  • MktCap 118771675.2082
  • FreeCF/Share -0.0583
  • PFCF -19.4912
  • PE -13.4059
  • Debt/Assets 0.1015
  • DivYield 0
  • ROE -0.5573

 

  • Rating D+
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Zentek Announces Upsizing of Non-Brokered Private Placement to up to $2,500,000
ZTEK
Published: October 20, 2025 by: Newsfile Corp
Sentiment: Neutral

Guelph, Ontario--(Newsfile Corp. - October 20, 2025) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company"), an intellectual property development and commercialization company is pleased to announce, further to its press release dated October 1, 2025, its previously announced non-brokered private placement of units (each, a "Unit") at a price of $1.06 per Unit (the "Offering") has been increased to up to 2,358,490 Units for gross proceeds of up to $2,500,000.

Read More
image for news Zentek Announces Upsizing of Non-Brokered Private Placement to up to $2,500,000
Zentek Announces Non-Brokered Private Placement of Units for up to $2,000,000
ZTEK
Published: October 01, 2025 by: Newsfile Corp
Sentiment: Neutral

Guelph, Ontario--(Newsfile Corp. - October 1, 2025) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company"), an intellectual property development and commercialization company, is pleased to announce its intention to complete a non-brokered private placement of up to $2,000,000 through the issuance of up to 1,886,792 units (the "Units") in the capital of the Company at a price of $1.06 per Unit (the "Offering").

Read More
image for news Zentek Announces Non-Brokered Private Placement of Units for up to $2,000,000
Zentek Announces Changes to Board of Directors and Changes to Board Nominations for Upcoming Annual and Special Meeting of Shareholders
ZTEK
Published: September 03, 2025 by: Accesswire
Sentiment: Neutral

GUELPH, ON / ACCESS Newswire / September 3, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN) an intellectual property technology development and commercialization company, today announces that Ilse Treurnicht has resigned from the Board of Directors effective immediately.

Read More
image for news Zentek Announces Changes to Board of Directors and Changes to Board Nominations for Upcoming Annual and Special Meeting of Shareholders

About Zentek Ltd. (ZTEK)

  • IPO Date 2012-04-02
  • Website https://www.zentek.com
  • Industry Medical - Instruments & Supplies
  • CEO Gregory Fenton
  • Employees 24

Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.